)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Poltreg
Poltreg (PTG) investor relations material
Poltreg Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary11 May, 2026
Executive summary
Focus on developing innovative Treg-based cell therapies for autoimmune diseases, with a leading global position in clinical development for type 1 diabetes and multiple sclerosis.
Achieved key milestones: eligibility letter from EMA for PTG-007, first GMP batch of CAR-TREG, and a licensing deal with City of Hope for CAR-Treg technology.
Raised 18.8 million PLN in a secondary public offering, increasing share capital to 591,645.60 PLN.
Financial highlights
Q1 2026 revenue: 2,582 thousand PLN, up from 1,798 thousand PLN year-over-year.
Net loss: 6,782 thousand PLN, compared to 5,471 thousand PLN in Q1 2025.
Operating cash flow: -8,410 thousand PLN (Q1 2025: -4,592 thousand PLN).
Cash at period end: 9,120 thousand PLN, down from 17,785 thousand PLN at year-end 2025.
Equity: 36,616 thousand PLN; total assets: 65,032 thousand PLN as of March 31, 2026.
Outlook and guidance
Strategic focus on partnering with major pharma for commercialization and further clinical development.
Plans for additional fundraising in 2027 if needed to reach key milestones.
Ongoing efforts to accelerate patient recruitment in preTreg clinical trials and expand R&D in the US.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Poltreg
- Net loss widened to 25.99m PLN as R&D and operating costs rose; major U.S. and EU regulatory progress.PTG
Q4 202530 Apr 2026 - Net loss nearly doubled as revenue fell, but key clinical and grant milestones were achieved.PTGQ2 202411 Mar 2026
- Revenue dropped sharply as clinical and regulatory progress accelerated, with losses offset by strong cash and grants.PTGQ4 202411 Mar 2026
- Losses increased as revenue fell, but clinical and patent milestones position the pipeline for future growth.PTGQ3 202411 Mar 2026
- Net loss widened on higher R&D costs, but clinical and regulatory milestones advanced.PTGQ3 202511 Mar 2026
- Q1 2025 marked higher losses, no sales, and key advances in TREG therapy R&D and partnerships.PTGQ1 202511 Mar 2026
- Net loss deepened, cash reserves fell, but major clinical and regulatory milestones were achieved.PTGQ2 202511 Mar 2026
Next Poltreg earnings date
Q2 20269 Sep, 2026
Poltreg
Next Poltreg earnings date
Q2 20269 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage